Atlas Trials

Cholangiocarcinoma of the Gallbladder

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Cholangiocarcinoma of the Gallbladder

RecordFirmDate
Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies (NCT03043547)AIO-Studien-gGmbH2017-10-24
CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery (NCT01766219)Wake Forest University Health Sciences2013-05-01
Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers (NCT01229111)National Cancer Institute (NCI)2010-10-01
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy (NCT00949949)Mayo Clinic2009-09-01
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors (NCT00356889)National Cancer Institute (NCI)2006-05-01
S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma (NCT00238212)National Cancer Institute (NCI)2005-10-01
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer (NCT00033462)National Cancer Institute (NCI)2002-03-01
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (NCT00028496)National Cancer Institute (NCI)2001-11-01
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer (NCT00023946)National Cancer Institute (NCI)2001-08-01
Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery (NCT00253617)Jonsson Comprehensive Cancer Center

Track Cholangiocarcinoma of the Gallbladder automatically

Every clearance here is in the API, with alerts when new ones post.